Chronic Kidney Disease in Small Animals

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 1, 2011, Pages 15-30

  Polzin, David J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anemia; Chronic kidney disease; Renal failure; Uremia

Indexed keywords

AMLODIPINE; BENAZEPRIL; BICARBONATE; CALCITRIOL; CITRATE POTASSIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOLASETRON MESILATE; ENALAPRIL; GLUCONATE POTASSIUM; IRON DEXTRAN; MAROPITANT; METOCLOPRAMIDE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ONDANSETRON; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN; TACHYKININ RECEPTOR ANTAGONIST;

ACID BASE BALANCE; ACIDOSIS; ALKALINIZATION THERAPY; ANEMIA; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; DEHYDRATION; DIET THERAPY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; FLUID THERAPY; GASTROINTESTINAL DISEASE; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOKALEMIA; KIDNEY FUNCTION TEST; METABOLIC ACIDOSIS; NAUSEA; NONHUMAN; PHYSICAL EXAMINATION; PROGNOSIS; PROTEIN RESTRICTION; PROTEINURIA; RECOMMENDED DRUG DOSE; RENAL DIET; REVIEW; THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; UREMIA; URINALYSIS; VOMITING;

ANIMALS; CAT DISEASES; CATS; DISEASE PROGRESSION; DOG DISEASES; DOGS; KIDNEY FAILURE, CHRONIC; SEVERITY OF ILLNESS INDEX;

ANIMALIA;

EID: 78651501245     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2010.09.004     Document Type: Review

References (50)

1. Polzin D. Chronic kidney disease. Textbook of veterinary internal medicine 2010, 2036-2067. Saunders. S. Ettinger, E. Feldman (Eds.).
2. Lees G.E., Brown S.A., Elliott J., et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). J Vet Intern Med 2005, 19:377-385.
3. Jacob F., Polzin D.J., Osborne C.A., et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. J Am Vet Med Assoc 2002, 220(8):1163-1170.
4. Elliott J., Rawlings J.M., Markwell P.J., et al. Survival of cats with naturally occurring chronic renal failure: effect of dietary management. J Small Anim Pract 2000, 41:235-242.
5. Ross S.J., Osborne C.A., Kirk C.A., et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 2006, 229:949-957.
6. Plantinga E.A., Everts H., Kastelein A.M.C., et al. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec 2005, 157:185-187.
7. Israel R., O'Mara V., Meyer B.R. Metoclopramide decreases renal plasma flow. Clin Pharmacol Ther 1986, 39:261-264.
8. Perkovic L.D., Rumboldt D., Bagatin Z., et al. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting. Kidney Blood Press Res 2002, 25:61-64.
9. Boyd L.M., Langston C., Thompson K., et al. Survival in cats with naturally occurring chronic kidney disease (200-2002). J Vet Intern Med 2008, 22:1111-1117.
10. King J.N., Tasker S., Gunn-More D.A., et al. Prognostic factors in cats with chronic kidney disease. J Vet Intern Med 2007, 21:906-916.
11. Block G., Hulbert-Shearon T., Levin N., et al. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998, 31:607-617.
12. Finco D., Brown S., Crowell W., et al. Effects of dietary phosphorus and protein in dogs with chronic renal failure. Am J Vet Res 1992, 53:2264-2271.
13. Elliot J., Brown S., Cowgill L., et al. Symposium on phosphatemia management in the treatment of chronic kidney disease 2006, Vetoquinol, Louisville (KY).
14. Fliser D., Koleritis B., Neyer U., et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study. J Am Soc Nephrol 2007, 18:2601-2608.
15. Segev G., Bandt C., Francey T., et al. Aluminum toxicity following administration of aluminum-based phosphate binders in 2 dogs with renal failure. J Vet Intern Med 2008, 22:1432-1435.
16. Elliot J., Barber P. Feline chronic renal failure: Clinical findings in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 1998, 39:78-85.
17. Nath K. The tubulointerstitium in progressive renal disease. Kidney Int 1998, 54:992-994.
18. Wesson D.E., Simoni J. Increased tissue acid mediates a progressive decline in glomerular filtration rate of animals with reduced nephron mass. Kidney Int 2009, 75:929-935.
19. Mitch W. Mechanisms causing loss of lean body mass in kidney disease. Am J Clin Nutr 1997, 67:359-366.
20. DiBartola S., Rutgers H., Zack P., et al. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc 1987, 190:1196-1202.
21. de Brito-Ashurst I., Varagunam M., Raftery M.J., et al. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 2009, 20:2075-2084.
22. Buranakarl C., Mathur S., Brown S.A. Effects of dietary sodium chloride intake on renal function and blood pressure in cats with normal and reduced renal function. Am J Vet Res 2004, 65:620-627.
23. Lulich J., Osborne C., O'Brien T., et al. Feline renal failure: questions, answers, questions. Compendium on Continuing Education for the Practicing Veterinarian 1992, 14:127-152.
24. Henik R., Snyder P., Volk L. Treatment of systemic hypertension in cats with amlodipine besylate. J Am Anim Hosp Assoc 1997, 33:226-234.
25. Dow S., Fettman M., LeCouteur R., et al. Potassium depletion in cats: renal and dietary influences. J Am Vet Med Assoc 1987, 191:1569-1575.
26. Dow S., Fettman M., Smith K., et al. Effects of dietary acidification and potassium depletion on acid-base balance, mineral metabolism and renal function in adult cats. J Nutr 1990, 120:569-578.
27. Theisen S., DiBartola S., Radin M., et al. Muscle potassium content and potassium gluconate supplementation in normokalemic cats with naturally occurring chronic renal failure. J Vet Intern Med 1997, 11:212-217.
28. Adams L., Polzin D., Osborne C., et al. Correlation of urine protein/creatinine ratio and twenty-four-hour urinary protein excretion in normal cats and cats with surgically induced chronic renal failure. J Vet Intern Med 1992, 6:36-40.
29. DiBartola S., Buffington C., Chew D., et al. Development of chronic renal disease in cats fed a commercial diet. J Am Vet Med Assoc 1993, 202:744-751.
30. Dow S., Fettman M. Renal disease in cats: the potassium connection. Current veterinary therapy xi 1992, 820-822. WB Saunders, Philadelphia. R. Kirk (Ed.).
31. Weir M., Fink J.C. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? a commentary. Am J Kidney Dis 2005, 45:176-188.
32. Cowgill L., James K., Levy J., et al. Use of recombinant humans erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 1998, 212:521-528.
33. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006, 355:2085-2098.
34. Gutierrez O., Isakova T., Rhee E., et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accelerates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005, 16:2205-2215.
35. Nagode L., Chew D., Podell M. Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure: both are essential to prevent or suppress toxic hyperparathyroidism. Vet Clin North Am 1996, 26:1293-1330.
36. Andress D.L. Vitamin D in chronic kidney disease: a systemic role for selective vitamin receptor activation. Kidney Int 2006, 69:33-43.
37. Pörsti I.H. Expanding targets of vitamin D receptor activation: downregulation of several RAS components in the kidney. Kidney Int 2008, 74:1371-1373.
38. Freundlich M., Quiroz Y., Zhang Z., et al. Suppression of renin-angiotensin gene expression in the kidney by paracalcitol. Kidney Int 2008, 74:1394-1402.
39. Shoben A.B., Rudser K.D., de Boer I.A., et al. Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 2008, 19:1613-1619.
40. Cheng S., Coyne D. Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 2007, 16:77-82.
41. Schenck P.A., Chew D.J. Determination of calcium fractionation n dogs with chronic renal failure. Am J Vet Res 2003, 64:1181-1184.
42. Hostutler R.A., DiBartola S.P., Chew D.J., et al. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure. J Vet Intern Med 2006, 20:1307-1313.
43. Jacob F., Polzin D.J., Osborne C.A., et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am Vet Med Assoc 2005, 226:393-400.
44. Syme H.M., Markwell P.J., Pfeiffer D., et al. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006, 20:528-535.
45. King J.N., Gunn-Moore D.A., Séverine Tasker S., et al. Tolerability and efficacy of benazepril in cats with chronic kidney disease. J Vet Intern Med 2006, 20:1054-1064.
46. Grauer G., Greco D., Getzy D., et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med 2000, 14:526-533.
47. Grodecki K.M., Gains M.J., Baumal R., et al. Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol 1997, 117:209-225.
48. Plumb D.C. Plumb's veterinary drug handbook 2008, Blackwell Publishing, Ames(IA), p. 130-1. 6th edition.
49. Brown S.A., Atkins C., Bagley R., et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 2007, 21:542-558.
50. Jacob F., Polzin D., Osborne C., et al. Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. J Am Vet Med Assoc 2003, 222:322-329.